TB drug price drop is a welcome relief as South Africa faces budget constrains
South Africa will now be paying 40% less for the multidrug-resistant tuberculosis (MDR-TB) drug bedaquiline. Bedaquiline is a key component in the cocktail of drugs used to treat MDR-TB. Pharmaceutical giant Johnson & Johnson (J&J) is currently the sole manufacturer…